Pediatrics
Conference Coverage
Game over: VTE is a risk in obese, sedentary teens
MONTREAL – We all know about the risk of VTE on planes. What about that for obese children and adolescents?
Conference Coverage
Watchful waiting a suitable option for pediatric acute ITP
MONTREAL – Treatment of acute idiopathic thrombocytopenic purpura does not appear to increase risk of later chronic ITP, except in children up to...
Conference Coverage
In sickle cell disease, osteomyelitis is a tough call
MONTREAL – How could ESR change osteomyelitis diagnosis in patients with SCD?
Conference Coverage
Cord blood/placental cell combo induces rapid immune recovery
MONTREAL – The probability of 1-year survival in children with severe diseases requiring stem cell transplants was 81%.
Conference Coverage
Routine surveillance adds cost but little benefit following a pediatric tumor
MONTREAL – It can be a tough sell to worried patients or their caregivers, but surveillance imaging in children with a history of some treated...
News
FDA approves first ready-to-use oral solution of methotrexate
The US Food and Drug Administration (FDA) has approved a ready-to-use oral solution of methotrexate (Xatmep) for use in certain pediatric patients...
Conference Coverage
Treatment-related hypertension, kidney injury are undertreated in kids with leukemia
MONTREAL – Chemotherapy-related hypertension and acute kidney injury can go unrecognized in children and young adults with ALL and AML.
Conference Coverage
Modifying CAR-T with IL-15 improved activity in glioma models
Adding an immunostimulatory cytokine to CAR-T improved the adaptive immunotherapy’s activity against aggressive pediatric brain malignancies.
News
Fertility treatments linked to risk of pediatric cancers
Children born to mothers who underwent fertility treatments have an increased risk of developing pediatric neoplasms, according to research...
From the Journals
Prognostic tool may allow tailored therapy for Hodgkin lymphoma
A newly developed “robust and inexpensive” prognostic tool may allow more tailored therapy for youth with intermediate-risk Hodgkin lymphoma.
Commentary
DTC genetic health risk tests: Beware
The Food and Drug Administration recently authorized 23andMe to provide consumers with results of germline DNA sequence variants associated with...